PETROSCRAPS.COM

Elixir Medical Corporation Announces Excellent Nine Month Safety And Efficacy Results From The EXCELLA II Randomized … Elixir Medical Corporation, a developer of product platforms combining state-of-the-art medical devices with advanced pharmaceuticals, announced today the superiority of the Elixir DESyne stent compared to the control Endeavor stent in the primary endpoint of the EXCELLA II randomized clinical trial. The Elixir DESyne Stent is the first drug eluting stent with the thinnest durable polymer … Read more on Medical News…. Click Here to Read More